NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/21/2023
Back to search
Official data from USPTO
H HOVIONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000076086641Class
1, 10, 35, 40, 42
Filing
76086641
Registration
2638210
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/23/2023
Trademark type
Combined
Nice classes
1, 10, 35, 40, 42
Filing date
07/11/2000
Registration date
10/22/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2023
Last transaction
10/23/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
09/01/1999
First use in commerce
09/01/1999
Drawing code
3
Owner type
03
Owner location
Loures, PT
Examiner
FARRELL, ANNE M
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
HOVIONE FARMACIENCIA, S.A.
Hovione Sociedade Quimica S.A.
Representatives
Bradford C. Craig Blank Rome LLP
Technical classification
Nice Classes
Class 1Class 10Class 35Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
bulk chemicals used in the manufacture of human and animal pharmaceutical products and housemark for a line of active pharmaceutical ingredients sold in bulk form for pharmaceutical products for human and animal use
Class 10
medical devicesinhalers for therapeutic use sold empty
Class 35
outsourcing services for others in the field of pharmaceuticals
Class 40
manufacture of active ingredients for pharmaceutical products to the order and specification of others
Class 42
research and development of new active ingredients for pharmaceutical products for others
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/21/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/20/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
04/24/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/22/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/28/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/28/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/28/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
09/13/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/21/2009
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/23/2008
PLGL
ASSIGNED TO PARALEGAL
10/22/2008
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/16/2008
E815
TEAS SECTION 8 & 15 RECEIVED
10/16/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/04/2008
CFIT
CASE FILE IN TICRS
01/10/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2002
PAPER RECEIVED
08/14/2002
PUBO
PUBLISHED FOR OPPOSITION
07/30/2002
NPUB
NOTICE OF PUBLICATION
07/10/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/02/2002
DOCK
ASSIGNED TO EXAMINER
03/28/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2001
CNRT
NON-FINAL ACTION MAILED
09/17/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2001
CNRT
NON-FINAL ACTION MAILED
12/21/2000
DOCK
ASSIGNED TO EXAMINER
12/04/2000
Continuous trademark protection
Get notified about every new filing that threatens H HOVIONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.